CALL/PFIZER INC/40/0.1/21.03.25 | Real-time BOERSE MUENCHEN 14:27:03 2024-06-24 EDT | ||
| 0.02 EUR | 0.00% |
|
| Current month | -33.33% | ||
| 1 month | -35.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 0.02 | 0.00% |
| 24-06-21 | 0.02 | 0.00% |
| 24-06-20 | 0.02 | 0.00% |
| 24-06-19 | 0.02 | +5.26% |
| 24-06-18 | 0.019 | +5.56% |
Real-time BOERSE MUENCHEN
Last update June 24, 2024 at 02:27 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | Goldman Sachs |
| WKN | GQ8T1Q |
| ISIN | DE000GQ8T1Q2 |
| Date issued | 2023-11-09 |
| Strike | 40 $ |
| Maturity | 2025-03-21 (270 Days) |
| Parity | 10 : 1 |
| Emission price | 0.09 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.099 € |
|---|---|
| Lowest since issue | 0.017 € |
| Spread | 0.003 € |
| Spread % | 13.04% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.36
USD
Average target price
31.92
USD
Spread / Average Target
+12.54%
- Stock Market
- Warrants
- Warrant
